QBIO — Q BioMed Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $9.26m
- $0.28m
Annual balance sheet for Q BioMed, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 2.68 | 0.173 | 0.177 | 0.344 | 0.05 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | 0.08 | 0.012 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 2.7 | 0.19 | 0.223 | 0.459 | 0.072 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 3.2 | 0.64 | 0.623 | 0.809 | 3.52 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.429 | 5.24 | 1.7 | 5.49 | 8.13 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.3 | 5.69 | 1.7 | 5.49 | 8.13 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.106 | -5.05 | -1.08 | -4.69 | -4.62 |
Total Liabilities & Shareholders' Equity | 3.2 | 0.64 | 0.623 | 0.809 | 3.52 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |